Cite
Prospective Clinical and Biomarker Validation of the American Society for Transplantation and Cellular Therapy Consensus Definition for Transplantation-Associated Thrombotic Microangiopathy.
MLA
Ma, Shengling, et al. “Prospective Clinical and Biomarker Validation of the American Society for Transplantation and Cellular Therapy Consensus Definition for Transplantation-Associated Thrombotic Microangiopathy.” Transplantation and Cellular Therapy, vol. 29, no. 11, Nov. 2023, p. 685.e1-685.e7. EBSCOhost, https://doi.org/10.1016/j.jtct.2023.08.015.
APA
Ma, S., Bhar, S., Guffey, D., Kim, R. B., Jamil, M., Amos, C. I., Lee, S. J., Hingorani, S. R., Sartain, S. E., & Li, A. (2023). Prospective Clinical and Biomarker Validation of the American Society for Transplantation and Cellular Therapy Consensus Definition for Transplantation-Associated Thrombotic Microangiopathy. Transplantation and Cellular Therapy, 29(11), 685.e1-685.e7. https://doi.org/10.1016/j.jtct.2023.08.015
Chicago
Ma, Shengling, Saleh Bhar, Danielle Guffey, Rock Bum Kim, Mahrukh Jamil, Christopher I Amos, Stephanie J Lee, Sangeeta R Hingorani, Sarah E Sartain, and Ang Li. 2023. “Prospective Clinical and Biomarker Validation of the American Society for Transplantation and Cellular Therapy Consensus Definition for Transplantation-Associated Thrombotic Microangiopathy.” Transplantation and Cellular Therapy 29 (11): 685.e1-685.e7. doi:10.1016/j.jtct.2023.08.015.